Chemours Q1 Loss Deepens to $(0.19) EPS as Revenue Sees Modest Gain
CC has more than doubled off its 52-week low of $9.13.
Summary
The Chemours Company reported a net loss of $(29) million for Q1 2026, resulting in a diluted loss per share of $(0.19). This represents a significant worsening from the $(5) million net loss and $(0.03) diluted loss per share reported in the year-ago quarter, despite a modest 0.9% increase in revenue to $1,381 million. This continued unprofitability follows a substantial $386 million net loss for fiscal year 2025, indicating persistent financial challenges. The deepening loss is a material negative development that could pressure the stock, as it suggests a lack of progress in improving the company's bottom line. Traders will be closely watching for management's detailed explanation of the increased losses and their strategy to achieve profitability.
At the time of this announcement, CC was trading at $27.18 on NYSE in the Manufacturing sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $9.13 to $28.67. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.